- Home
- MOLN vs RMNI Comparison
MOLN vs RMNI Comparison
Compare MOLN & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- RMNI
- Stock Information
- Founded
- MOLN 2004
- RMNI 2005
- Country
- MOLN Switzerland
- RMNI United States
- Employees
- MOLN N/A
- RMNI N/A
- Industry
- MOLN
- RMNI Business Services
- Sector
- MOLN
- RMNI Consumer Discretionary
- Exchange
- MOLN Nasdaq
- RMNI Nasdaq
- Market Cap
- MOLN 195.4M
- RMNI 256.4M
- IPO Year
- MOLN 2021
- RMNI N/A
- Fundamental
- Price
- MOLN $5.56
- RMNI $2.82
- Analyst Decision
- MOLN
- RMNI Buy
- Analyst Count
- MOLN 0
- RMNI 2
- Target Price
- MOLN N/A
- RMNI $6.00
- AVG Volume (30 Days)
- MOLN 7.1K
- RMNI 338.5K
- Earning Date
- MOLN 03-13-2025
- RMNI 02-26-2025
- Dividend Yield
- MOLN N/A
- RMNI N/A
- EPS Growth
- MOLN N/A
- RMNI N/A
- EPS
- MOLN N/A
- RMNI N/A
- Revenue
- MOLN $7,105,397.00
- RMNI $426,650,000.00
- Revenue This Year
- MOLN N/A
- RMNI N/A
- Revenue Next Year
- MOLN $29.41
- RMNI N/A
- P/E Ratio
- MOLN N/A
- RMNI N/A
- Revenue Growth
- MOLN N/A
- RMNI N/A
- 52 Week Low
- MOLN $3.32
- RMNI $1.53
- 52 Week High
- MOLN $12.70
- RMNI $3.43
- Technical
- Relative Strength Index (RSI)
- MOLN 53.39
- RMNI 60.75
- Support Level
- MOLN $4.98
- RMNI $2.71
- Resistance Level
- MOLN $5.91
- RMNI $2.86
- Average True Range (ATR)
- MOLN 0.27
- RMNI 0.17
- MACD
- MOLN 0.08
- RMNI -0.00
- Stochastic Oscillator
- MOLN 69.45
- RMNI 78.57
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About RMNI Rimini Street Inc. (DE)
Rimini Street Inc is a provider of enterprise software support products and services and a third-party support provider for Oracle and SAP software products based in the United States. The company offers solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. Some of its products include Oracle E-business suite, Oracle Database, Peoplesoft, SAP business suite, and others. The company derives maximum revenue from United states.